These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9699705)

  • 1. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE; Emslie GJ; Mayes TL
    J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
    Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
    Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M; Adityanjee ; Jampala C
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract]   [Full Text] [Related]  

  • 7. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA; Millaud F; Nguyen KA
    Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS; Chang W; Lee HK; Cook MS
    J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caution is still needed when prescribing atypical antipsychotics.
    Carey S
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ; Hopwood MJ; Morris PL
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic interaction between risperidone and clozapine: a case report.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Christodoulou GN
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):407-9. PubMed ID: 11817521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G; Lewis R; Konas S; Loebstein O; Goldberg P; Burguillo F; Nahshoni E; Munitz H
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    Matheson KM; Gray G
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.